Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    patient advocates

    • Home
    • patient advocates
    A modern, multi-story medical and research center with glass and metal facades, brightly lit interiors, and surrounding trees. A street with crosswalks and traffic signs runs in front of the building.
    Tumor Board, Research

    Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    July 22, 2025 joshs Comments Off on Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach. These new members, along with our existing institutions, greatly enhance our ability to develop and implement cutting-edge, individualized treatment plans.

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (4)
    • Dr. Theodore Laetsch (3)
    • Education (6)
    • Healthcare (4)
    • Latest News (6)
    • Research (14)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A virtual meeting with five professionally dressed people, each appearing in separate screens. Three men and two women are smiling or looking attentive, seated in well-lit indoor settings. Names and titles are visible on screen.
      Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum
    • Two scientists in protective clothing and masks work in a laboratory; one is looking through a microscope while the other stands beside, observing and discussing the research.
      Rethinking the Driver: New Research Identifies P300 as a Critical Co-Factor in Synovial Sarcoma
    • A doctor in a white coat and stethoscope writes on a clipboard while standing in a medical office or hospital room. Medical equipment and a bed are visible in the background.
      Synovial Sarcoma Treatment Market Projected to Grow Through 2031: What This Means for Patients

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant innovate treaments JAMA Internal Medicine Julie Kramer MAGE-A4 Market Growth Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications P300 Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TCR-NK TECELRA webinar Zelluna ZI-MA4-1

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch